Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 2/20 | 0.42 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.37 |
| ▸ | CCNK | O75909 | 2/20 | 0.36 |
| ▸ | CDK12 | Q9NYV4 | 2/20 | 0.36 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.36 |
| ▸ | KDM5A | P29375 | 1/20 | 0.35 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.35 |
| ▸ | KDR | P35968 | 7/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | MPO | P05164 | 1/20 | 0.34 |
| ▸ | TPO | P07202 | 1/20 | 0.34 |
| ▸ | LPO | P22079 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | TAS2R38 | P59533 | 1/20 | 0.34 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.33 |
| ▸ | VCP | P55072 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.32 |
| ▸ | PDK4 | Q16654 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18342027 | 0.86 | PARP1 (0.35) | PDGFRBCCNKCDK12HCAR2KDR | |
| SCHEMBL3647958 | 0.73 | TRPA1 (0.44) | KIT | |
| SCHEMBL9048053 | 0.71 | ABL1 (0.35) | EGFRKIT | |
| SCHEMBL15828666 | 0.69 | IKBKB (0.38) | KIT | |
| SCHEMBL24541944 | 0.68 | ADORA1 (0.43) | ADORA1ADORA2ACCNKCDK12KDM5A | |
| SCHEMBL20536455 | 0.67 | PDK2 (0.38) | ADORA1ADORA2APDGFRBCCNKCDK12 | |
| SCHEMBL26677299 | 0.66 | — | — | |
| SCHEMBL22502463 | 0.66 | IKBKB (0.38) | EGFRKDM4EKIT | |
| SCHEMBL15062514 | 0.66 | DAO (0.46) | EGFRTSHRCYP2C19KDM4ELMNA | |
| SCHEMBL2231375 | 0.65 | NOS2 (0.41) | HCAR2TSHRCYP2C19KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2897957-A1 | SUBSTITUTED PYRROLOPYRIMIDINYLAMINO-BENZOTHIAZOLONES AS MKNK KINASE INHIBITORS | Bayer Pharma Aktiengesellschaft (DE) | 2015-07-29 | — | — | EP | disclosed |
| WO-2014044691-A1 | SUBSTITUTED PYRROLOPYRIMIDINYLAMINO-BENZOTHIAZOLONES AS MKNK KINASE INHIBITORS | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2014-03-27 | — | — | WO | disclosed |
| US-20100113606-A1 | AMINOPROPANOL MODULATORS OF BETA-1 ADRENERGIC RECEPTOR | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113606-A1 | AMINOPROPANOL MODULATORS OF BETA-1 ADRENERGIC RECEPTOR | ADRB1, ADRB2, ADRB3 | ADORA1 31/4885ADORA2A 72/4885PDGFRB 350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.